In a study published by Wan et al [74], where 8396 consecutive patients with breast cancer after surgery were included, no survival benefit was shown in carriers with BRCA1 and BRCA2 who underwent BCT compared with those who underwent mastectomy with or without radiotherapy. The gene discussed is BRCA2; the disease is breast cancer.